Cargando…
Azole-Induced Myositis after Combined Lung-Liver Transplantation
Lung transplant recipients experience a high rate of invasive pulmonary aspergillosis infections, for which voriconazole is the treatment of choice. We report a patient who developed voriconazole-induced myositis that relapsed after one dose of isavuconazole. Our patient was a 38-year-old man who re...
Autores principales: | Happaerts, Sofie, Wieërs, Michiel, Vander Mijnsbrugge, Ward, Godinas, Laurent, Van Raemdonck, Dirk, Ceulemans, Laurens J., Vos, Robin, Verleden, Geert M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957034/ https://www.ncbi.nlm.nih.gov/pubmed/35345837 http://dx.doi.org/10.1155/2022/7323755 |
Ejemplares similares
-
Commentary: Donor lungs allocated to critically ill patients listed urgently: No longer a waste of precious organs?
por: Van Raemdonck, Dirk, et al.
Publicado: (2021) -
Peripheral Blood Eosinophilia Is Associated with Poor Outcome Post-Lung Transplantation
por: Kaes, Janne, et al.
Publicado: (2020) -
Interaction between posaconazole and flucloxacillin in a lung transplant patient: decrease in plasma exposure of posaconazole and possible undertreatment of invasive aspergillosis: case report
por: Verfaillie, Saartje, et al.
Publicado: (2022) -
Case Report: An Unusual Course of Angiosarcoma After Lung Transplantation
por: Bos, Saskia, et al.
Publicado: (2022) -
The MUC5B Promoter Polymorphism is Not Associated With Non-ILD Chronic Respiratory Diseases or Post-transplant Outcome
por: Goos, Tinne, et al.
Publicado: (2022)